Vascular closure devices and methods for closing a blood vessel puncture site disposed at a distal end of a tissue tract are described. A combination of the body's own natural mechanism with chemical and/or biological agents is relied upon to accelerate the hemostatic process. Included are steps of introducing a closure device through the tissue tract and deploying an expansible member at a distal end of the device within the blood vessel to occlude the puncture site. A sealing member disposed proximal the expansible member is then displaced by retracting and tensioning a coil spring so as to expose a chemical and/or biological region or release region of the device. The retraction and tensioning of the coil spring is limited by a coupling member. Exposure of blood and tissue to the chemical and/or biological sealing member promotes the clotting processing to accelerate the occlusion process in the tract.

Implementations of a delivery device and method are disclosed. One implementation is a delivery device comprising a flow chamber with an inlet port for receiving a fluid flow in the flow chamber, and an outlet port for exiting a material from the flow chamber. The flow chamber may include a formation portion in which a suspension of the material is formed, and a collection portion that directs the suspension toward and/or into the outlet port. An amount of the material may collect in the collection portion adjacent the outlet port. The device may further comprise an insertion port for permitting insertion of the material in the flow chamber, and/or a pusher operable to move the amount of material through the outlet port. Related devices and methods also are disclosed.

Implantable fully-endovascular mammalian body succedent cavity wall breach sealing device comprising a support frame having compact and expanded configuration. Cavity wall barrier membrane tensioned by the frame. Membrane having a tensioned penetrable zone when. Device having a delivery configuration in which the frame is in its compact configuration, the membrane is unpenetrated, and the device is deliverable transcatheterly to a remote implantation site. Deployed configuration in which the frame is in its expanded configuration for anchoring the device in place at the implantation site. Device being positionable with such that when in its deployed configuration it has a single lumen in continuity with a native fluid flow path within the body cavity formed by the support frame. Penetrable zone abuts wall of the body cavity to be succedently traversed by a catheter. Penetrable zone permitting penetration of the catheter into the single lumen, and self-sealing around an exterior surface thereof.

A system may include a delivery device configured to deploy a perianal fistula closure device and the perianal fistula closure device configured to close a perianal fistula. The delivery device may include a helical catheter. The perianal fistula closure device may include a cap, a suture comprising a plurality of uni-directional barbs, and an anchor connected to an end of the suture comprising a plurality of uni-directional quills.

A device for occluding a perforation in a blood vessel includes a catheter shaft that has a first lumen and a second lumen. The first lumen is adapted to receive at least one of a guidewire and an implanted cardiac lead, and the second lumen is adapted to receive an inflation fluid. The device further includes an inflatable balloon that is carried by the catheter shaft. The inflatable balloon is adapted to receive the inflation fluid from the second lumen. The inflatable balloon has a working length of about 65 mm to about 80 mm and an inflated diameter of about 20 mm to about 25 mm.

In one aspect, the present invention provides a device for occluding an aperture in a body, for example, a patent foramen ovale (PFO), including a first side adapted to be disposed on one side of the septum and a second side adapted to be disposed on the opposite side of the septum. The device has an elongated, low-profile delivery configuration and a shortened, radially expanded deployment configuration. The first and second sides are adapted to occlude the aperture upon deployment of the device at its intended delivery location. The device also includes a radially expandable center portion. In some embodiments, the center portion includes a plurality of ribs provided by slits in device. The ribs expand radially when the device is deployed. The expandable center portion facilitates the positioning of the device in the aperture. The device can be secured in the deployed configuration using a catch system.

An occlusive implant includes an expandable framework that is configured to shift between a collapsed configuration and an expanded configuration. An occlusive member is disposed along at least a portion of the expandable framework. At least part of the occlusive implant is configured to repel fibrinogen. In some cases, the occlusive implant may be configured for placement within a left atrial appendage (LAA) of a patient's heart.

Device and method embodiments discussed herein are directed to mechanical closure of an access passage in a tissue layer adjacent to an access hole in a vessel such as an artery or vein of a patient. Some of these embodiments may also be applicable to direct closure of a vessel wall in some instances.

An implantable closure device can comprise a self-expanding metal frame comprising a central portion defining a lumen and a plurality of first anchoring arms and a plurality of second anchoring arms angularly spaced around the central portion. The central portion can comprise a sinusoidal-shaped ring defining a plurality of apices. The first anchoring arms can be connected to locations inside of the apices on a first side of the central portion and the second anchoring arms can be connected to locations inside of the apices on a second side of the central portion. The first anchoring arms can be configured to bear against a first surface of a septal wall. The second anchoring arms can be configured to bear against a second surface of the septal wall.

A device for occluding a perforation in a blood vessel includes an expandable member. The expandable member includes a central expandable balloon disposed between a proximal and a distal balloon, wherein the proximal and distal balloons each contain first and second compositions, respectively. The proximal, central and distal balloons have respective stiffnesses, and the central balloon has a third stiffness that is less than the first and second stiffnesses. Upon expansion, the central balloon causes the proximal balloon and the distal balloon to substantially simultaneously release the first and second compositions, thereby allowing the first composition and the second composition to combine in-situ and form, therein, a biocompatible foam to occlude a perforation within the vasculature.